Searched over 200M research papers
10 papers analyzed
These studies suggest that radiation therapy for cancer involves precise treatment that affects cancer cell DNA, subcellular structures, and the tumor microenvironment, but may also promote metastasis and resistance, with potential benefits when combined with immunotherapy.
20 papers analyzed
Radiation therapy, also known as radiotherapy, is a cornerstone in the management of cancer, utilized in approximately 50% of all cancer patients at some point during their treatment . This modality involves the use of high-energy radiation to destroy cancer cells by damaging their DNA, either directly or indirectly through the generation of reactive oxygen species (ROS) . The primary goal of radiation therapy is to inhibit the proliferation of cancer cells, thereby reducing tumor size and preventing metastasis.
Radiation therapy exerts its effects primarily by inducing DNA damage. This can occur directly through ionization or indirectly via ROS, which cause single and double-strand breaks in the DNA helix . These breaks activate DNA damage sensors, leading to cell cycle arrest, apoptosis, or necrosis if the damage is irreparable . Additionally, radiation affects various subcellular structures, including the cytoplasmic membrane, endoplasmic reticulum, and mitochondria, further disrupting cancer cell function.
An intriguing phenomenon associated with radiation therapy is the radiation-induced bystander effect (RIBE). This effect occurs when non-irradiated cells exhibit similar responses to those directly exposed to radiation, likely due to signaling molecules released by irradiated cells. Understanding RIBE is crucial as it can influence the overall therapeutic efficacy and side effects of radiation therapy.
Radiation therapy not only targets cancer cells but also significantly alters the tumor microenvironment (TME). It can modulate the immune response by releasing tumor-derived antigens and danger signals, which can trigger anti-tumor immunity . However, tumors can develop resistance to radiation, partly due to changes in the TME and immune cell infiltration . Combining radiation with immunotherapy is a promising approach to enhance the anti-tumor effects and overcome resistance .
Despite its efficacy, radiation therapy can paradoxically promote metastasis and the expansion of cancer stem cells (CSCs). Ionizing radiation (IR) can induce epithelial-mesenchymal transition (EMT), a process that enhances the invasive and metastatic potential of cancer cells . Additionally, IR can increase the population of CSCs, which are highly tumorigenic and contribute to tumor recurrence and resistance to therapy .
Technological advancements in radiotherapy, such as improved imaging and computer technology, have significantly enhanced the precision and effectiveness of treatment . These innovations allow for more accurate targeting of tumors, minimizing damage to surrounding healthy tissues. Ongoing research aims to further understand the biological responses of cancer cells to radiation, which could lead to more effective and personalized treatment strategies .
Radiation therapy remains a vital component of cancer treatment, offering significant survival benefits for many patients. By understanding the complex biological effects of radiation on cancer cells and the tumor microenvironment, researchers and clinicians can continue to improve therapeutic outcomes and reduce adverse effects. Combining radiation with other modalities, such as immunotherapy, holds promise for enhancing the efficacy and durability of cancer treatments.
Most relevant research papers on this topic